🇺🇸 FDA
Pipeline program

0.3% ropivacaine and 50 μg dexmedetomidine

Dexmedetomidine in nerve block

Approved small_molecule active

Quick answer

0.3% ropivacaine and 50 μg dexmedetomidine for Free Flap Reconstruction is a Approved program (small_molecule) at China SXT Pharmaceuticals with 1 ClinicalTrials.gov record(s).

Program details

Company
China SXT Pharmaceuticals
Indication
Free Flap Reconstruction
Phase
Approved
Modality
small_molecule
Status
active

Clinical trials